Marksans-Pharma Stock/Share Prices, Buy and Sell Marksans-Pharma BSE Stocks

Market Snapshot

BSE Sensex: 40904.71 0.89%
BSE 500: 15581.04 0.76%
BSE 200: 5034.58 0.77%
BSE 100: 12048.58 0.78%
BSE Mid-Cap: 14888.16 0.77%
BSE Small-Cap: 14989.52 0.63%
BANKEX: 28110.67 1.88%
BSE IT Sector: 22133.38 0.42%
Nifty 50: 11988.5 0.77%
Nifty 500: 9800.65 0.70%
Nifty 200: 6163.15 0.71%
Nifty 100: 12062.65 0.72%
Nifty Midcap 100: 17138.2 0.68%
Nifty Small 100: 5947.65 0.73%
Nifty IT: 21799.65 0.49%
Nifty PSU Bank: 1322 1.33%

News:

IEX Q2 PAT slips 9% to Rs 44 c...
Financials stocks rise...
Banking shares gain...
Metal stocks spurt...
Gujarat Ambuja Exports Ltd Fal...

Marksans Pharma Ltd NSE / BSE
Pharmaceuticals, Small Cap

Invest

21 Oct 2020 | 10:36 AM

50.80

0.10 (0.20%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

243.01%

Return (1Y)

Beaten S&P BSE Healthcare by 188.92%
More Volatile

4.44%

Standard Deviation (1Y)

Higher than S&P BSE Healthcare by 2.79%
Consistent Performer

8/12

Months

beaten S&P BSE Healthcare
AxisDirect View

No View

52 Week High-Low

News & Announcements

Board of Marksans Pharma appoints director
47 days ago

Board of Marksans Pharma appoints director

03 - Sep - 2020 12:00 AM | 47 days ago

The Board of Marksans Pharma at its meeting held on 03 September 2020 has appointed Dr. Meena Rani Surana, subject to approval of the members at a general meeting, as an Independent Woman Director of the Company for a term of five (5) consecutive years with effect from 3 September, 2020 not liable to retire by rotation.
Powered by Capital Market - Live News
Marksans Pharma to conduct AGM
62 days ago

Marksans Pharma to conduct AGM

19 - Aug - 2020 12:00 AM | 62 days ago

Marksans Pharma announced that the 28th Annual General Meeting (AGM) of the company will be held on 29 September 2020.
Powered by Capital Market - Live News
Marksans Pharma consolidated net profit rises 119.62% in the June 2020 quarter
77 days ago

Marksans Pharma consolidated net profit rises 119.62% in the June 2020 quarter

04 - Aug - 2020 12:00 AM | 77 days ago

Net profit of Marksans Pharma rose 119.62% to Rs 49.37 crore in the quarter ended June 2020 as against Rs 22.48 crore during the previous quarter ended June 2019. Sales rose 35.15% to Rs 331.15 crore in the quarter ended June 2020 as against Rs 245.03 crore during the previous quarter ended June 2019.
Particulars Quarter Ended
Jun. 2020 Jun. 2019 % Var.
Sales 331.15 245.03 35
OPM % 21.14 13.23 -
PBDT 68.65 32.35 112
PBT 61.40 27.61 122
NP 49.37 22.48 120
Powered by Capital Market - Live News
Marksans Pharma to table results
87 days ago

Marksans Pharma to table results

25 - Jul - 2020 12:00 AM | 87 days ago

Marksans Pharma will hold a meeting of the Board of Directors of the Company on 4 August 2020.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Marksans Pharma Ltd has increased by 13.91% since past 3 Months
FII shareholding in Marksans Pharma Ltd has increased by 34.28% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Jun. 2020	Jun. 2019	% Var.
Sales	331.15	245.03	35
OPM %	21.14	13.23	-
PBDT	68.65	32.35	112
PBT	61.40	27.61	122
NP	49.37	22.48	120

General Notifications

My Notifications

Research Notifications

Marksans Pharma Ltd NSE / BSE Pharmaceuticals, Small Cap

50.80 0.10 (0.20%)

News & Announcements

Price vs Volume

Stock Trivia

Marksans Pharma Ltd NSE / BSE
Pharmaceuticals, Small Cap

50.80

0.10 (0.20%)